companydata.dkcompanydata.dk

Vesper Bio ApS: Financial statements 2024

CVR: 32879861

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -67,243,983 and a net result of DKK -66,506,349 compared with DKK -52,563,302 the year before. Equity in the 2024 report amounted to DKK -179,232,248. The company had 9 employees in the financial year.

Gross Profit
DKK -67,243,983
Profit/Loss
DKK -66,506,349
Equity
DKK -179,232,248
Total Assets
DKK 69,848,972
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--67.2 mio.-66.5 mio.-179.2 mio.9
2023--67.6 mio.-52.6 mio.-112.7 mio.6
2022--31.6 mio.-36.9 mio.-60.2 mio.1
2021--13.5 mio.-16.5 mio.-23.3 mio.0
2020--6.8 mio.-8 mio.-6.8 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Vesper Bio ApS: The 2023 annual report is outMar 5, 2024

Vesper Bio ApS has published its annual report for 2023. Gross profit came to DKK -67,586,405, and the net result was DKK -52,563,302.

About Vesper Bio ApS

Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.

Source: annual report 2025, Danish Business Authority